Loading…

Immune Responses to Invasive Group B Streptococcal Disease in Adults

Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infecti...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2016-11, Vol.22 (11), p.1877-1883
Main Authors: Edwards, Morven S, Rench, Marcia A, Rinaudo, C Daniela, Fabbrini, Monica, Tuscano, Giovanna, Buffi, Giada, Bartolini, Erika, Bonacci, Stefano, Baker, Carol J, Margarit, Immaculada
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1883
container_issue 11
container_start_page 1877
container_title Emerging infectious diseases
container_volume 22
creator Edwards, Morven S
Rench, Marcia A
Rinaudo, C Daniela
Fabbrini, Monica
Tuscano, Giovanna
Buffi, Giada
Bartolini, Erika
Bonacci, Stefano
Baker, Carol J
Margarit, Immaculada
description Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infection in nonpregnant adults. Prospective surveillance from 7 hospitals in Houston, Texas, USA, identified 102 adults with GBS bacteremia; 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis. CPS-specific IgG was determined by ELISA and pilus-specific IgG by multiplex immunoassay. CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods. Pili, expressed by 89%, were most often PI-2a. CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI. All GBS expressed CPS or PI; 79% expressed both. Increased antibodies to CPS and PI during recovery suggests that GBS bacteremia in adults is potentially vaccine preventable.
doi_str_mv 10.3201/eid2211.160914
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2b3d6abda7494c3997bb1b7d16d70d7b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A472266308</galeid><doaj_id>oai_doaj_org_article_2b3d6abda7494c3997bb1b7d16d70d7b</doaj_id><sourcerecordid>A472266308</sourcerecordid><originalsourceid>FETCH-LOGICAL-d481t-6aa725c08214b7f42e85a054092d086a4685ccacb402597881f4ea8337731b8d3</originalsourceid><addsrcrecordid>eNqN0t9r1TAUB_Aiivuhrz5KQZD50Gt-NUkfr5vOwmCwqa_lNDm9y2ibrkmH_vdm3jm8cB8kDwmHz_kGTpJlbyhZcUboR3SWMUpXVJKKimfZISWaFJKU1fOnsyAH2VEIt4TQ1FK9zA6YUlIRog-zs3oYlhHzKwyTHwOGPPq8Hu8huHvMz2e_TPmn_DrOOEVvvDHQ52cuIATM3Ziv7dLH8Cp70UEf8PXjfpx9__L52-nX4uLyvD5dXxRWaBoLCaBYaYhmVLSqEwx1CaQUpGKWaAlC6jJdYFpBWFkprWknEDTnSnHaasuPs3qbaz3cNtPsBph_NR5c86fg500Dc3Smx4a13EpoLShRCcOrSrUtbZWl0ipiVZuyTrZZ0-zvFgyxGVww2Pcwol9CQzUvy4epskTfbekGUrIbOx9nMA-8WQvFmJSc6KSKPWqDI87Q-xE7l8o7frXHp2VxcGZvw4edhmQi_owbWEJo6uur_7eXP3bt-3_sDUIfb4Lvl-jSh9iFbx9HtrQD2qcH-Pub-G_Jt8Th</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835516092</pqid></control><display><type>article</type><title>Immune Responses to Invasive Group B Streptococcal Disease in Adults</title><source>PubMed Central</source><creator>Edwards, Morven S ; Rench, Marcia A ; Rinaudo, C Daniela ; Fabbrini, Monica ; Tuscano, Giovanna ; Buffi, Giada ; Bartolini, Erika ; Bonacci, Stefano ; Baker, Carol J ; Margarit, Immaculada</creator><creatorcontrib>Edwards, Morven S ; Rench, Marcia A ; Rinaudo, C Daniela ; Fabbrini, Monica ; Tuscano, Giovanna ; Buffi, Giada ; Bartolini, Erika ; Bonacci, Stefano ; Baker, Carol J ; Margarit, Immaculada</creatorcontrib><description>Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infection in nonpregnant adults. Prospective surveillance from 7 hospitals in Houston, Texas, USA, identified 102 adults with GBS bacteremia; 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis. CPS-specific IgG was determined by ELISA and pilus-specific IgG by multiplex immunoassay. CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods. Pili, expressed by 89%, were most often PI-2a. CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI. All GBS expressed CPS or PI; 79% expressed both. Increased antibodies to CPS and PI during recovery suggests that GBS bacteremia in adults is potentially vaccine preventable.</description><identifier>ISSN: 1080-6040</identifier><identifier>EISSN: 1080-6059</identifier><identifier>DOI: 10.3201/eid2211.160914</identifier><identifier>PMID: 27767008</identifier><language>eng</language><publisher>United States: U.S. National Center for Infectious Diseases</publisher><subject>Adult ; adult invasive infection ; Aged ; Aged, 80 and over ; Antibodies, Bacterial - blood ; Antibodies, Bacterial - immunology ; Antibody Specificity - immunology ; Bacteremia ; bacteria ; capsular polysaccharide ; Development and progression ; Female ; group B Streptococcus ; Humans ; Immune response ; Immunoglobulin G - blood ; Immunoglobulin G - immunology ; Male ; Middle Aged ; Molecular Typing ; pilus island ; Polysaccharides, Bacterial - immunology ; Serotyping ; Streptococcal infections ; Streptococcal Infections - diagnosis ; Streptococcal Infections - immunology ; Streptococcal Infections - microbiology ; Streptococcus agalactiae - classification ; Streptococcus agalactiae - genetics ; Streptococcus agalactiae - immunology ; Streptococcus agalactiae - isolation &amp; purification ; Testing</subject><ispartof>Emerging infectious diseases, 2016-11, Vol.22 (11), p.1877-1883</ispartof><rights>COPYRIGHT 2016 U.S. National Center for Infectious Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27767008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Edwards, Morven S</creatorcontrib><creatorcontrib>Rench, Marcia A</creatorcontrib><creatorcontrib>Rinaudo, C Daniela</creatorcontrib><creatorcontrib>Fabbrini, Monica</creatorcontrib><creatorcontrib>Tuscano, Giovanna</creatorcontrib><creatorcontrib>Buffi, Giada</creatorcontrib><creatorcontrib>Bartolini, Erika</creatorcontrib><creatorcontrib>Bonacci, Stefano</creatorcontrib><creatorcontrib>Baker, Carol J</creatorcontrib><creatorcontrib>Margarit, Immaculada</creatorcontrib><title>Immune Responses to Invasive Group B Streptococcal Disease in Adults</title><title>Emerging infectious diseases</title><addtitle>Emerg Infect Dis</addtitle><description>Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infection in nonpregnant adults. Prospective surveillance from 7 hospitals in Houston, Texas, USA, identified 102 adults with GBS bacteremia; 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis. CPS-specific IgG was determined by ELISA and pilus-specific IgG by multiplex immunoassay. CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods. Pili, expressed by 89%, were most often PI-2a. CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI. All GBS expressed CPS or PI; 79% expressed both. Increased antibodies to CPS and PI during recovery suggests that GBS bacteremia in adults is potentially vaccine preventable.</description><subject>Adult</subject><subject>adult invasive infection</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antibodies, Bacterial - immunology</subject><subject>Antibody Specificity - immunology</subject><subject>Bacteremia</subject><subject>bacteria</subject><subject>capsular polysaccharide</subject><subject>Development and progression</subject><subject>Female</subject><subject>group B Streptococcus</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin G - immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular Typing</subject><subject>pilus island</subject><subject>Polysaccharides, Bacterial - immunology</subject><subject>Serotyping</subject><subject>Streptococcal infections</subject><subject>Streptococcal Infections - diagnosis</subject><subject>Streptococcal Infections - immunology</subject><subject>Streptococcal Infections - microbiology</subject><subject>Streptococcus agalactiae - classification</subject><subject>Streptococcus agalactiae - genetics</subject><subject>Streptococcus agalactiae - immunology</subject><subject>Streptococcus agalactiae - isolation &amp; purification</subject><subject>Testing</subject><issn>1080-6040</issn><issn>1080-6059</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqN0t9r1TAUB_Aiivuhrz5KQZD50Gt-NUkfr5vOwmCwqa_lNDm9y2ibrkmH_vdm3jm8cB8kDwmHz_kGTpJlbyhZcUboR3SWMUpXVJKKimfZISWaFJKU1fOnsyAH2VEIt4TQ1FK9zA6YUlIRog-zs3oYlhHzKwyTHwOGPPq8Hu8huHvMz2e_TPmn_DrOOEVvvDHQ52cuIATM3Ziv7dLH8Cp70UEf8PXjfpx9__L52-nX4uLyvD5dXxRWaBoLCaBYaYhmVLSqEwx1CaQUpGKWaAlC6jJdYFpBWFkprWknEDTnSnHaasuPs3qbaz3cNtPsBph_NR5c86fg500Dc3Smx4a13EpoLShRCcOrSrUtbZWl0ipiVZuyTrZZ0-zvFgyxGVww2Pcwol9CQzUvy4epskTfbekGUrIbOx9nMA-8WQvFmJSc6KSKPWqDI87Q-xE7l8o7frXHp2VxcGZvw4edhmQi_owbWEJo6uur_7eXP3bt-3_sDUIfb4Lvl-jSh9iFbx9HtrQD2qcH-Pub-G_Jt8Th</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Edwards, Morven S</creator><creator>Rench, Marcia A</creator><creator>Rinaudo, C Daniela</creator><creator>Fabbrini, Monica</creator><creator>Tuscano, Giovanna</creator><creator>Buffi, Giada</creator><creator>Bartolini, Erika</creator><creator>Bonacci, Stefano</creator><creator>Baker, Carol J</creator><creator>Margarit, Immaculada</creator><general>U.S. National Center for Infectious Diseases</general><general>Centers for Disease Control and Prevention</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>IOV</scope><scope>ISR</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>201611</creationdate><title>Immune Responses to Invasive Group B Streptococcal Disease in Adults</title><author>Edwards, Morven S ; Rench, Marcia A ; Rinaudo, C Daniela ; Fabbrini, Monica ; Tuscano, Giovanna ; Buffi, Giada ; Bartolini, Erika ; Bonacci, Stefano ; Baker, Carol J ; Margarit, Immaculada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d481t-6aa725c08214b7f42e85a054092d086a4685ccacb402597881f4ea8337731b8d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>adult invasive infection</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antibodies, Bacterial - immunology</topic><topic>Antibody Specificity - immunology</topic><topic>Bacteremia</topic><topic>bacteria</topic><topic>capsular polysaccharide</topic><topic>Development and progression</topic><topic>Female</topic><topic>group B Streptococcus</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin G - immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular Typing</topic><topic>pilus island</topic><topic>Polysaccharides, Bacterial - immunology</topic><topic>Serotyping</topic><topic>Streptococcal infections</topic><topic>Streptococcal Infections - diagnosis</topic><topic>Streptococcal Infections - immunology</topic><topic>Streptococcal Infections - microbiology</topic><topic>Streptococcus agalactiae - classification</topic><topic>Streptococcus agalactiae - genetics</topic><topic>Streptococcus agalactiae - immunology</topic><topic>Streptococcus agalactiae - isolation &amp; purification</topic><topic>Testing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Edwards, Morven S</creatorcontrib><creatorcontrib>Rench, Marcia A</creatorcontrib><creatorcontrib>Rinaudo, C Daniela</creatorcontrib><creatorcontrib>Fabbrini, Monica</creatorcontrib><creatorcontrib>Tuscano, Giovanna</creatorcontrib><creatorcontrib>Buffi, Giada</creatorcontrib><creatorcontrib>Bartolini, Erika</creatorcontrib><creatorcontrib>Bonacci, Stefano</creatorcontrib><creatorcontrib>Baker, Carol J</creatorcontrib><creatorcontrib>Margarit, Immaculada</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Gale in Context : Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Emerging infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Edwards, Morven S</au><au>Rench, Marcia A</au><au>Rinaudo, C Daniela</au><au>Fabbrini, Monica</au><au>Tuscano, Giovanna</au><au>Buffi, Giada</au><au>Bartolini, Erika</au><au>Bonacci, Stefano</au><au>Baker, Carol J</au><au>Margarit, Immaculada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune Responses to Invasive Group B Streptococcal Disease in Adults</atitle><jtitle>Emerging infectious diseases</jtitle><addtitle>Emerg Infect Dis</addtitle><date>2016-11</date><risdate>2016</risdate><volume>22</volume><issue>11</issue><spage>1877</spage><epage>1883</epage><pages>1877-1883</pages><issn>1080-6040</issn><eissn>1080-6059</eissn><abstract>Immunization of nonpregnant adults could help prevent invasive group B Streptococcus (GBS) infections, but adult immune responses have not been investigated. We defined capsular polysaccharide (CPS) and pilus island (PI) surface antigen distribution and expression and immune responses to GBS infection in nonpregnant adults. Prospective surveillance from 7 hospitals in Houston, Texas, USA, identified 102 adults with GBS bacteremia; 43% had skin/soft tissue infection, 16% bacteremia without focus, and 12% osteomyelitis. CPS-specific IgG was determined by ELISA and pilus-specific IgG by multiplex immunoassay. CPS types were Ia (24.5%), Ib (12.7%), II (9.8%), III (16.7%), IV (13.7%), and V (12.7%); 9.8% were nontypeable by serologic methods. Pili, expressed by 89%, were most often PI-2a. CPS and pilus-specific IgG increased during convalescence among patients with strains expressing CPS or PI. All GBS expressed CPS or PI; 79% expressed both. Increased antibodies to CPS and PI during recovery suggests that GBS bacteremia in adults is potentially vaccine preventable.</abstract><cop>United States</cop><pub>U.S. National Center for Infectious Diseases</pub><pmid>27767008</pmid><doi>10.3201/eid2211.160914</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1080-6040
ispartof Emerging infectious diseases, 2016-11, Vol.22 (11), p.1877-1883
issn 1080-6040
1080-6059
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2b3d6abda7494c3997bb1b7d16d70d7b
source PubMed Central
subjects Adult
adult invasive infection
Aged
Aged, 80 and over
Antibodies, Bacterial - blood
Antibodies, Bacterial - immunology
Antibody Specificity - immunology
Bacteremia
bacteria
capsular polysaccharide
Development and progression
Female
group B Streptococcus
Humans
Immune response
Immunoglobulin G - blood
Immunoglobulin G - immunology
Male
Middle Aged
Molecular Typing
pilus island
Polysaccharides, Bacterial - immunology
Serotyping
Streptococcal infections
Streptococcal Infections - diagnosis
Streptococcal Infections - immunology
Streptococcal Infections - microbiology
Streptococcus agalactiae - classification
Streptococcus agalactiae - genetics
Streptococcus agalactiae - immunology
Streptococcus agalactiae - isolation & purification
Testing
title Immune Responses to Invasive Group B Streptococcal Disease in Adults
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A53%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20Responses%20to%20Invasive%20Group%20B%20Streptococcal%20Disease%20in%20Adults&rft.jtitle=Emerging%20infectious%20diseases&rft.au=Edwards,%20Morven%20S&rft.date=2016-11&rft.volume=22&rft.issue=11&rft.spage=1877&rft.epage=1883&rft.pages=1877-1883&rft.issn=1080-6040&rft.eissn=1080-6059&rft_id=info:doi/10.3201/eid2211.160914&rft_dat=%3Cgale_doaj_%3EA472266308%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d481t-6aa725c08214b7f42e85a054092d086a4685ccacb402597881f4ea8337731b8d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835516092&rft_id=info:pmid/27767008&rft_galeid=A472266308&rfr_iscdi=true